Advertisement
Advertisement
CGEN
Compugen Ltd
2.90
USDSponsored
+0.04
+1.40%
May 08, 16:00 UTC -4
Closed
After-Market
2.92
+0.02
+0.86%
CGEN Earnings Reports
Positive Surprise Ratio
CGEN beat 29 of 40 last estimates.
73%
Next Report
Next Week
Date of Next Report
May 18, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.14M
/-$0.07
Implied change from Q4 25 (Revenue/ EPS)
-96.83%
/-111.67%
Implied change from Q1 25 (Revenue/ EPS)
-6.43%
/-12.50%
Compugen Ltd earnings per share and revenue
On Mar 02, 2026, CGEN reported earnings of 0.60 USD per share (EPS) for Q4 25, beating the estimate of 0.05 USD, resulting in a 1076.47% surprise. Revenue reached 67.33 million, compared to an expected 1.38 million, with a 4765.72% difference. The market reacted with a +24.31% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 2.14 million USD, implying an decrease of -111.67% EPS, and decrease of -96.83% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Iovance Biotherapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.19
Surprise
-24.35%
Corvus Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.15
Surprise
-2.95%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
Ginkgo Bioworks Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.09
Actual
-$1.28
Surprise
-17.35%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Codexis, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.10
Surprise
+28.26%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
PTC Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.47
Actual
-$0.03
Surprise
+93.75%
Scholar Rock Holding Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.81
Actual
-$0.83
Surprise
-1.62%
FAQ
What were Compugen Ltd's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Compugen Ltd reported EPS of $0.60, beating estimates by 1076.47%, and revenue of $67.33M, 4765.72% above expectations.
How did the market react to Compugen Ltd's Q4 2025 earnings?
The stock price moved up 24.31%, changed from $1.81 before the earnings release to $2.25 the day after.
When is Compugen Ltd expected to report next?
The next earning report is scheduled for May 18, 2026.
What are the forecasts for Compugen Ltd's next earnings report?
Based on 4
analysts, Compugen Ltd is expected to report EPS of -$0.07 and revenue of $2.14M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement